Cargando…
Glioblastoma Treatment in the Elderly
Although current treatment advances prolong patient survival, treatment for glioblastoma (GBM) in the elderly has become an emerging issue. The definition of “elderly” differs across articles; GBM predominantly occurs at an age ≥65 years, and the prognosis worsens with increasing age. Regarding mole...
Autores principales: | OKADA, Masaki, MIYAKE, Keisuke, TAMIYA, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735230/ https://www.ncbi.nlm.nih.gov/pubmed/29081442 http://dx.doi.org/10.2176/nmc.ra.2017-0009 |
Ejemplares similares
-
Usefulness of Positron Emission Tomographic Studies for Gliomas
por: MIYAKE, Keisuke, et al.
Publicado: (2016) -
STMO-15 OUR THERAPEUTIC STRATEGIES FOR GLIOBLASTOMA: INTRAOPERATIVE SUPPORT SYSTEMS [INTRAOPERATIVE MRI, PET, 5-AMINOLEVULINIC ACID (5-ALA)] AND NEOADJUVANT CHEMOTHERAPY
por: Miyake, Keisuke, et al.
Publicado: (2019) -
ET-04 MOLECULAR TARGETED THERAPY AGAINST (PRO)RENIN RECEPTOR FOR GLIOBLASTOMA
por: Fujimori, Takeshi, et al.
Publicado: (2019) -
BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021) -
Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas
por: Miyake, Keisuke, et al.
Publicado: (2012)